ISA Pharmaceuticals
Hendrik Zonnenberg is Director of Investments at Multifund B.V., a privately held investment office. Prior to that he was an equity analyst at ING Investment Banking (1999-2003). Mr. Zonnenberg holds an M.Sc. in Economics from the University in Groningen.
This person is not in the org chart
This person is not in any offices
ISA Pharmaceuticals
ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology.